PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-11-03

Date Title Company
03-Nov-2025 FluoGuide A/S Issue Warrants to Board Members, Executive Management and Employees ACCESS Newswire
03-Nov-2025 Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting ACCESS Newswire
03-Nov-2025 FluoGuide A/S Completes Directed Share Issue of SEK 104 Million ACCESS Newswire
03-Nov-2025 The Assistance Fund Opens New Program for Macular Telangiectasia ACCESS Newswire
03-Nov-2025 FluoGuide A/S Intends to Carry Out a Directed Share Issue of Approximately SEK 100 Million ACCESS Newswire
03-Nov-2025 Reprieve House Opens Silicon Valley's First Premium Detox Facility ACCESS Newswire
03-Nov-2025 Richmond Pharmacology Welcomes Back Dr Edward Jackson as Medical Director Richmond Pharmacology
03-Nov-2025 Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna Avance Clinical
03-Nov-2025 Voters and researchers head to Parliament to see how politicians are using evidence Sense About Science
03-Nov-2025 Breast Imaging Market Share Leaders, Market Analysis, Developments and Regional Forecast 2028 Medi-Tech Insights
03-Nov-2025 Bioburden Testing Market Size, Share, Growth, Trends and Forecast to 2029 Medi-Tech Insights
03-Nov-2025 Medical Care Technologies, Inc (OTC PINK:MDCE) Announces Development of AI-Powered Wellness App Suite with Global Reach ACCESS Newswire
03-Nov-2025 BioInvent to Present Early Phase 2a Data from Ongoing Trial with Triple Combination of BI-1206, Rituximab, and Calquence in r/r NHL, at ASH 2025 ACCESS Newswire
03-Nov-2025 BioInvent to Present Updated Phase 2a BI-1808 Monotherapy Data in CTCL at ASH 2025 ACCESS Newswire
03-Nov-2025 Nomination Committee Appointed in Respect of AGM 2026 in Alligator Bioscience AB ACCESS Newswire
03-Nov-2025 CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting ACCESS Newswire
03-Nov-2025 Nomination Committee for Senzime Annual General Meeting 2026 ACCESS Newswire
03-Nov-2025 Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules ACCESS Newswire
03-Nov-2025 Biohope Announces Collaboration to Advance Immunobiogram for Renal Transplant ACCESS Newswire
03-Nov-2025 Prolocor Announces Publication in Journal of Invasive Cardiology. Prolocor pFCG Test is a Powerful Prognostic Marker of Ischemic Risk Early After Myocardial Infarction (MI). ACCESS Newswire